Emergent BioSolutions Inc. - Common Stock (EBS)

Historical Holders from Q1 2014 to Q3 2025

Symbol: EBS on NYSE
Type / Class: Equity / Common Stock
Shares outstanding: 54,486,781
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 41,696,731
Holdings value: $352,475,779
% of all portfolios: 0%
Number of holders: 167
Number of buys: 83
Number of sells: -83
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Emergent BioSolutions Inc. - Common Stock (EBS)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
BlackRock, Inc.	7.3%		$25,376,673		3,977,535		BlackRock, Inc.	30 Jun 2025

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	41,696,731	$352,475,779	+$19,667,118	$2,265,306	$7,050,840	$8.82	167
2025 Q2	36,048,259	$229,963,501	+$8,627,423	$1,000,491	$1,909,509	$6.38	159
2025 Q1	36,190,861	$175,869,555	+$2,175,881	$740,188	$457,326	$4.86	158
2024 Q4	34,731,466	$332,026,231	+$28,116,282	$1,934,475	$3,197,378	$9.56	155
2024 Q3	31,685,912	$264,526,545	+$30,958,222	$7,756,431	$3,699,640	$8.35	137
2024 Q2	30,424,097	$207,508,937	-$26,587,800	$4,817,648	$935,022	$6.82	137
2024 Q1	35,915,952	$90,810,710	-$12,044,764	$190,003	$199,111	$2.53	115
2023 Q4	40,884,124	$98,125,874	-$3,033,553	$163,440	$129,840	$2.4	129
2023 Q3	41,326,491	$140,783,681	-$26,266,322	$327,420	$153,680	$3.4	159
2023 Q2	45,670,504	$335,708,725	+$1,389,547	$848,943	$798,294	$7.35	177
2023 Q1	44,931,082	$465,319,997	-$16,940,760	$1,014,244	$1,146,852	$10.36	187
2022 Q4	46,237,482	$546,050,427	+$42,157,405	$323,594	$846,989	$11.81	193
2022 Q3	40,630,823	$852,783,613	-$48,608,549	$987,000	$1,220,000	$20.99	192
2022 Q2	41,191,389	$1,278,322,431	-$19,204,360	$854,000	$3,654,000	$31.04	217
2022 Q1	41,761,849	$1,714,987,525	-$22,633,768	$2,165,000	$4,386,000	$41.06	234
2021 Q4	42,514,559	$1,849,372,320	-$107,864,716	$5,759,000	$5,287,000	$43.47	243
2021 Q3	44,511,870	$2,228,860,734	-$18,391,350	$4,539,000	$4,679,000	$50.07	270
2021 Q2	44,739,294	$2,817,444,749	-$43,662,628	$13,106,000	$10,003,000	$62.99	286
2021 Q1	44,459,246	$4,122,801,151	+$64,719,540	$11,634,000	$9,939,000	$92.91	334
2020 Q4	44,267,661	$3,967,537,088	+$93,758,805	$17,487,000	$16,020,000	$89.6	350
2020 Q3	42,899,052	$4,434,039,819	-$189,544,769	$5,791,000	$9,918,000	$103.33	355
2020 Q2	53,497,347	$4,185,752,138	+$625,343,109	$4,594,000	$6,381,000	$79.08	295
2020 Q1	44,884,797	$2,596,632,152	+$7,885,727	$2,146,000	$1,481,000	$57.86	257
2019 Q4	44,601,650	$2,406,425,656	-$6,082,616	$2,638,000	$561,000	$53.95	232
2019 Q3	44,748,551	$2,338,743,757	-$21,935,074	$2,708,000	$314,000	$52.28	241
2019 Q2	45,520,096	$2,198,644,219	+$64,447,863	$0	$0	$48.31	229
2019 Q1	44,845,040	$2,265,671,390	+$80,862,293	$1,875,000	$1,657,000	$50.52	265
2018 Q4	43,083,866	$2,553,149,934	+$34,101,099	$1,096,000	$2,261,000	$59.28	293
2018 Q3	42,429,433	$2,792,382,193	+$14,853,355	$2,219,000	$3,094,000	$65.83	269
2018 Q2	42,572,970	$2,149,894,709	+$23,723,394	$348,000	$212,000	$50.49	257
2018 Q1	42,080,510	$2,209,520,816	+$57,029,193	$0	$1,354,000	$52.65	270
2017 Q4	40,397,491	$1,878,364,516	+$151,859,986	$1,293,000	$679,000	$46.47	234
2017 Q3	37,088,695	$1,500,432,961	+$64,446,291	$2,079,000	$2,892,000	$40.45	193
2017 Q2	35,621,344	$1,199,488,524	+$6,414,221	$5,061,000	$1,767,000	$33.91	179
2017 Q1	35,579,837	$1,033,330,673	+$100,066,486	$568,000	$366,000	$29.04	173
2016 Q4	35,742,013	$1,173,028,889	-$3,279,137	$778,000	$1,307,000	$32.84	204
2016 Q3	35,869,477	$1,129,692,915	-$1,485,647	$1,129,000	$4,168,000	$31.53	197
2016 Q2	36,161,934	$1,016,934,072	+$82,512,424	$8,947,000	$1,670,000	$28.12	215
2016 Q1	33,583,921	$1,221,359,935	+$19,065,121	$5,241,000	$2,635,000	$36.35	211
2015 Q4	32,446,135	$1,298,005,471	+$24,674,059		$404,000	$40.01	202
2015 Q3	32,168,577	$916,516,058	+$35,690,135		$322,000	$28.49	191
2015 Q2	31,043,093	$1,022,845,909	+$25,560,178		$0	$32.95	181
2015 Q1	30,395,864	$874,182,011	+$38,137,574		$101,000	$28.76	169
2014 Q4	29,096,913	$792,405,069	-$719,286			$27.23	163
2014 Q3	28,825,281	$614,994,160	-$30,742			$21.31	158
2014 Q2	28,744,311	$645,587,994	-$436,657		$0	$22.46	157
2014 Q1	28,580,751	$722,288,209	+$89,513,027		$286,000	$25.27	163